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Abstract Leader peptidase is an integral membrane protein of
E. coli and it catalyses the removal of most signal peptides from
translocated precursor proteins. In this study it is shown that
when the transmembrane anchors are removed in vivo, the
remaining catalytic domain can bind to inner and outer
membranes of E. coli. Furthermore, the purified catalytic domain
binds to inner membrane vesicles and vesicles composed of
purified inner membrane lipids with comparable efficiency. It is
shown that the interaction is caused by penetration of a part of
the catalytic domain between the lipids. Penetration is mediated
by phosphatidylethanolamine, the most abundant lipid in E. coli,
and does not seem to depend on electrostatic interactions. A
hydrophobic segment around the catalytically important residue
serine 90 is required for the interaction with membranes.
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1. Introduction
For recognition by the export machinery, proteins are usu-
ally synthesized as precursors with amino terminal extensions
called leader or signal sequences. Signal sequences contain a
hydrophobic core region which is preceded by an amino ter-
minal positively charged domain [1]. After translocation signal
sequences are removed by the action of leader (signal) pepti-
dases which cleave 5^7 residues downstream of the hydropho-
bic core of the signal sequence [1]. In E. coli, signal sequences
are removed by Lep (also called leader peptidase or signal
peptidase I) which is encoded by the LepB gene [2]. It requires
a turn inducing residue (glycine or proline) at position 36 and
small residues, preferably alanine, at positions 33 and 31
with respect to the cleavage site [3,4].
Lep is comprised of an amino terminal part containing two
transmembrane helices (H1 and H2) separated by a highly
positively charged cytosolic loop (P1), and a large, carboxy-
terminal periplasmic domain (P2) (Fig. 1A). Site-directed mu-
tagenesis studies have suggested that the proteolytic mecha-
nism involves a serine at position 90 and a lysine at 145, and
that all residues required for cleavage are located in the P2
domain [5,6]. Serine 90 is positioned in a mildly hydrophobic
segment (H3).
The substrates for Lep are membrane bound. There is com-
pelling evidence that during translocation the amino terminus
of the signal peptide stays at the cytosolic side of the mem-
brane [7,8], while the hydrophobic core is probably too short
to span the membrane. This means that in order to reach its
substrate, the catalytic site of Lep must be in or very close to
the membrane. One of the possible ways to achieve this is by a
direct interaction between the catalytic domain and lipid con-
stituents of the membrane.
In this paper interactions between the periplasmic domain
of leader peptidase and lipids are reported. The ability of
di¡erent Lep constructs to interact with biomembranes and
arti¢cial membranes has been studied. In particular, one con-
struct (v2-75) with very good catalytic activity [9] and lacking
the membrane-anchoring H1-P1-H2 domain shows a pro-
nounced ability to penetrate into pure lipid bilayers and
monolayers with a speci¢city for the zwitterionic lipid phos-
phatidylethanolamine. The results are discussed in relation to
the mode of action of Lep.
2. Materials and methods
2.1. Isolation and puri¢cation of proteins and lipids
Two truncated forms of Lep, v2-75 and v2-98, were isolated essen-
tially as described before [9,10] but detergent was left out. The pro-
teins were stored in 20 mM Tris-HCl, pH 7.4. Total lipid extracts
from the inner membrane were prepared by extraction [11] and further
puri¢ed by column chromatography on a silica column (silicagel 30^
60 Wm, Baker BV). After equilibration in chloroform, phospholipids
were eluted in a chloroform/methanol 1:1 (v/v) mixture and converted
to their sodium salts [12]. 1,2-Dioleoyl-sn-glycero-3-phosphocholine
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were purchased
from Avanti Polar Lipids (Birmingham, AL, USA).
2.2. Subcellular fractionation
An overnight culture of E. coli strain MC1061 [13] bearing a plas-
mid encoding the H2-CC construct [14] was diluted into fresh M9
medium [15] supplemented with ampicillin (50 Wg/ml), 0.2% fructose,
thiamin and all amino acids except for methionine. Expression was
induced during early-exponential phase with 0.2% arabinose and cells
were labelled with 50 WCi [35S]methionine. After 2 min cells were
harvested by centrifugation for 2 min at 13 krpm in an Eppendorf
centrifuge, washed and resuspended in 30 mM Tris-HCl, pH 7.5. An
equal volume of the same bu¡er with 40% sucrose (w/v) and EDTA
(¢nal concentration 0.1 mM) was added and the mixture was incu-
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bated at room temperature for 10 min. Cells were pelleted and the
pellet was quickly resuspended in ice cold 0.5 mM MgCl2 and incu-
bated on ice for 10 min. After centrifugation for 8 min the super-
natant was separated from the pellet. Both pellet and supernatant
fractions were immunoprecipitated with Lep and L-lactamase antibod-
ies and analysed by SDS-PAGE followed by autoradiography.
Inner and outer membrane fractions of MC1061 expressing H2-CC
were essentially prepared as described in the next section. Cells were
grown in LB medium supplemented with ampicillin (50 Wg/ml) and
induced with 0.2% arabinose in early exponential phase. After one
hour of induction the cells were harvested by 15 min centrifugation
at 6 krpm in a GSA rotor (Sorvall).
2.3. Vesicle isolation and preparation
Inverted and right-side out inner membrane vesicles and outer
membranes of E. coli strain MC1061 were isolated according to pub-
lished procedures [16,17]. The identity of the fractions was con¢rmed
by lipopolysaccharide staining and immunodetection of OmpA, Lep
and SecY. Large unilamellar vesicles (LUVETs) were prepared by
means of extrusion through a polycarbonate ¢lter (Nucleopore; 0.2
Wm pore size) of a rehydrated (10 mM Tris-HCl, 50 mM NaCl, pH
7.5) total lipid extract from the inner membrane of MC1061.
2.4. Vesicle binding assay
LUVETs corresponding to 200 nmol lipid were incubated with the
indicated amounts of protein (Fig. 3B) in 300 Wl 10 mM Tris-HCl, 50
mM NaCl, pH 7.5, for 1 h at room temperature. Inner membrane
vesicles and outer membranes were incubated in 300 Wl 50 mM tri-
ethanolamine/HAc, 250 mM sucrose, 1 mM DTT, pH 7.5, to main-
tain the same environment as during isolation. Vesicles were pelleted
by centrifugation for 30 min at 236U103 g at room temperature in a
TLA 100.3 rotor using a TL 100 ultracentrifuge (Beckmann Instru-
ments Inc., Palo Alto, CA, USA). Pelleting e⁄ciencies of the vesicles
were calculated after phosphorus determination [18] on supernatant
and pellet. The amount of bound protein was determined after SDS-
PAGE and Coomassie Brilliant Blue staining of pellet and superna-
tant fractions. The intensities of the bands were quanti¢ed by densi-
tometry (Personal Densitometer, Molecular Dynamics, Sunnyvale,
CA, USA) and compared to calibration curves of the same proteins
which were run on the same gels. The amount of bound protein was
corrected for the pelleting e⁄ciency of the vesicles which was always
above 80%. Control experiments without vesicles revealed that more
than 99% of the added proteins was recovered in the supernatant.
2.5. Monolayer experiments
The Wilhelmy plate method was used to measure protein induced
changes in surface pressure of a monomolecular layer of phospholip-
ids at constant surface area [19]. Surface pressures were measured at
26 þ 1‡C using a Cahn 2000 microbalance while continuously stirring
the subphase with a magnetic bar. Unless stated otherwise, a subphase
of 5 ml 10 mM Tris-HCl, 50 mM NaCl, pH 7.5, was placed in a te£on
trough. The monomolecular lipid layers were spread from a chloro-
form/methanol 3:1 (v/v) solution at the air/bu¡er interphase to give
initial surface pressures between 18 and 35 mN/m. Lower initial sur-
face pressures were not used since both proteins gave rise to surface
pressures of 18 mN/m in the absence of a lipid monolayer. In all
experiments saturating amounts of protein (for both proteins 4 Wg/
ml) were added in the subphase from a hole in the edge of the trough.
The surface pressure was measured until a constant level was reached.
3. Results
The catalytic domain of Lep is localised in the periplasm
[20]. To study possible interactions of this domain with mem-
branes in vivo, a mutant was required in which the catalytic
P2 domain could be separated from the membrane anchoring
H1-P1-H2 domain. To this end, we used a construct (H2-CC)
with a Lep cleavage site engineered downstream of H2 (Fig.
1A). This construct can be e⁄ciently expressed and is cleaved
in vivo, probably by the native population of Lep molecules in
the membrane [14]. When spheroplasts were prepared the
cleaved form was accessible to proteases ([14], results not
shown). Periplasmic fractions of pulse labelled cells expressing
H2-CC were isolated by osmotic shock and screened by im-
munoprecipitations. While most (75 þ 6%) of the periplasmic
marker protein L-lactamase was recovered in the soluble peri-
plasmic fraction, the cleaved domain of Lep was found pre-
dominantly in the pellet (84 þ 7%) (results not shown), sug-
gesting that the catalytic domain has an intrinsic ability to
associate with membranes.
To investigate more precisely the localisation of the peri-
plasmic domain, membrane fractions were prepared from cells
expressing H2-CC. Inner and outer membranes were sepa-
rated on a sucrose gradient and the di¡erent fractions were
analysed by SDS-PAGE. Antibodies against Lep were used to
stain blots made from the di¡erent fractions (Fig. 1B, insert).
Two bands reacted with the antibody. One of 36 kDa corre-
sponding to uncleaved, full-length Lep, was found mainly in
the inner membranes around fraction 8 and to a lesser extent
in the outer membrane (Fig. 1B, circles) as reported before
[21]. A band with an apparent molecular weight of approx-
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Fig. 1. The P2 domain of Lep fractionates both with the inner and
outer membrane. A: Orientation of leader peptidase in the inner
membrane and indication of the position of an engineered cleavage
cassette (CC) behind the second transmembrane helix. The amino
acid sequence of the region around H2 of a construct bearing a
cleavage cassette is depicted. H2 (from residue 68 to 76) is under-
lined and the cleavage cassette between residues 76 and 77 is de-
picted in italics. The most likely cleavage site is indicated by an ar-
row. B: The amount of full-length Lep and of the cleaved P2
domain was determined in fractions which were collected from a su-
crose gradient on which E. coli membranes were separated. The
amounts of full length Lep (circles) and cleaved form (squares) are
plotted against the fraction number. The inner and outer mem-
branes were found around fractions 8 and 20m respectively. The in-
sert shows the result of the corresponding Western blot decorated
with Lep antibody.
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imately 30 kDa, which is the size expected for the cleaved P2
domain, was associated with both membranes with a slight
preference for the outer membrane (Fig. 1B, squares).
The ability of the periplasmic domain of Lep to bind to
membranes was con¢rmed by vesicle binding experiments.
For this purpose we made use of a puri¢ed, enzymatically
active construct (v2-75, see Fig. 3A) lacking the H1-P1-H2
domain [9]. By means of ultracentrifugation experiments the
binding of v2-75 to right-side-out inner membrane vesicles
and outer membranes was determined. In the absence of
membranes, v2-75 was quantitatively recovered in the super-
natant after ultracentrifugation (Fig. 2, upper panel, lanes 1^
3). Right-side out inner membrane vesicles (Fig. 2, upper pan-
el, lanes 4^6) contain many di¡erent proteins as judged by
Coomassie Brilliant Blue staining of gels, while outer mem-
branes (Fig. 2, lower panel, lanes 1^3) show a characteristic
pattern with only two dominant bands. Both types of vesicles
were pelleted e⁄ciently. When v2-75 was incubated with
vesicles prior to centrifugation, a signi¢cant fraction of the
molecules sedimented with the vesicles (Fig. 2, upper panel,
lanes 7^9 and lower panel, lanes 4^6). Thus, v2-75 is appar-
ently capable of binding to both inner and outer membranes
while the native population of Lep is found mostly in the
inner membrane. This suggests that the periplasmic domain
does not require speci¢c inner membrane components for
binding. To investigate the possibility that the P2 domain
recognises the lipid component of membranes, the binding
of 5 Wg v2-75 to inner membranes and to unilamellar lipid
vesicles made from puri¢ed inner membrane lipids were com-
pared. The same amount of lipid phosphorus was used for
both types of vesicles. Right side out inner membrane vesicles
bound 1.7 þ 0.3 Wg of v2-75 while the lipid vesicles bound
1.6 þ 0.3 Wg, implying that membrane binding of v2-75 is
mediated by lipids.
To gain insight into the part of v2-75 responsible for mem-
brane activity, the lipid binding ability of v2-75 was compared
to that of construct v2-98 (Fig. 3A) which lacks the mildly
hydrophobic H3 segment. Fig. 3B shows e⁄cient binding of
v2-75 to the lipid vesicles (closed squares). The slightly sig-
moidal binding curve indicates that some cooperativity is in-
volved in the binding process. Strikingly, binding of v2-98
(open circles) is greatly reduced suggesting that the interaction
of the periplasmic domain of Lep is mediated via the H3
region.
The association of v2-75 with lipid vesicles can be caused
by binding to the surface as well as by insertion of a part of
the protein between the lipids. To study the nature and spe-
ci¢city of the interaction of the periplasmic domain of Lep
with lipids we made use of monolayer experiments. Lipids
isolated from puri¢ed inner membranes of E. coli were spread
at the air-water interface to an initial surface pressure of 22
mN/m (Fig. 4A). When a solution of v2-98 was injected under
the monolayer a fast but small increase in surface pressure
was observed which stabilised around 30 min. In contrast
v2-75 gave rise to a much larger pressure increase, indicating
a more e⁄cient interaction with the lipids, in accordance with
the vesicle binding data. Since proteins that only interact with
the lipid head groups without penetration between the lipids
do not give rise to a pressure increase [22], the results show
that v2-75 inserts e⁄ciently between the phospholipids in the
monolayer.
The limiting surface pressure is de¢ned as the maximal ini-
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Fig. 3. v2-75 binds more e⁄ciently to lipid vesicles than v2-98. A:
The second transmembrane segment H2 is underlined and a third
hydrophobic segment (H3) coloured gray. The catalytically impor-
tant serine-90 is shown in white. B: Binding of v2-75 (closed
squares) and v2-98 (open circles) to lipid vesicles was determined as
described in Section 2.
Fig. 2. Puri¢ed v2-75 associates both with inner and outer mem-
brane vesicles. Samples with (upper panel, lanes 1^3 and 7^9; lower
panel, lanes 4^6) or without v2-75 (upper panel, lanes 4^6; lower
panel, lanes 1^3) were incubated in the absence (upper panel, lanes
1^3) or presence of membranes before ultracentrifugation. After cen-
trifugation samples were split in pellet (p) and supernatant (s) frac-
tions and compared to the total (t) amount before centrifugation.
The upper panel shows incubations with inner membranes and the
lower panel with outer membranes. Gels were stained with Coomas-
sie Brilliant Blue.
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tial surface pressure at which a protein can cause an increase
in surface pressure. This parameter is a measure of the mem-
brane-penetrating ability of the protein. In biological mem-
branes the packing densities of the lipids correspond to sur-
face pressures between 31 and 35 mN/m [23]. To investigate
whether the P2-constructs are able to penetrate into mem-
branes with physiological lipid packing densities, monolayers
with di¡erent initial surface pressures were made. Fig. 4B
shows that the limiting surface pressure for v2-98 (squares)
is below the physiological threshold. In contrast, extrapola-
tion of the curve for v2-75 (circles) to zero surface pressure
increase reveals that this construct is able to insert into mono-
layers with initial pressures as high as 38 mN/m, suggesting
that the P2 domain is capable of penetrating into biological
membranes in vivo.
To study the lipid speci¢city of the P2-membrane interac-
tion, insertion into monolayers of pure lipids were compared.
Phosphatidyl ethanolamine (PE) has a zwitterionic headgroup
and accounts for approximately 75% of the phospholipids in
the E. coli inner membrane [24]. The second most abundant
lipid is the negatively charged phosphatidyl glycerol (PG)
which accounts for about 20% [24]. Insertion of v2-75 in a
monolayer of dioleoyl phosphatidyl ethanolamine (DOPE)
and dioleoyl phosphatidyl glycerol (DOPG) as representative
lipids was measured as function of the initial pressure. From
Fig. 5 it is clear that v2-75 inserts best (highest pressure in-
crease) into DOPE monolayers (triangles). Strikingly, inser-
tion into monolayers of negatively charged DOPG (circles)
was clearly less e⁄cient, indicating that penetration into the
monolayer was not mediated by attracting electrostatic inter-
actions in contrast to many other proteins [25]. This was con-
¢rmed by measuring the in£uence of the ionic strength of the
subphase on the ability of v2-75 to interact with monolayers
of E. coli lipids. Increasing the NaCl concentration up to 1.2
M did not lead to a decrease in the ability of v2-75 to pen-
etrate into the monolayer (results not shown).
To determine whether the zwitterionic character of DOPE
is the only factor responsible for the interaction, dioleoylphos-
phatidyl choline (DOPC) was also tested. Insertion into
DOPC monolayers (squares) was considerably less e⁄cient
despite the identical acyl chains, further illustrating the spe-
ci¢city of the interaction of v2-75 with PE.
4. Discussion
This study reports on the interaction of the catalytic do-
main of leader peptidase, one of the key enzymes in prepro-
tein translocation, with membranes. Evidence for membrane
binding activity was obtained using two approaches. Frac-
tionation studies with the construct H2-CC from which the
membrane spanning regions are cleaved from the periplasmic
domain in vivo showed that the periplasmic domain is asso-
ciated both with inner and outer membranes indicating no
high a⁄nity for speci¢c components of the inner membrane.
This ¢nding was con¢rmed by studies using the puri¢ed v2-75
construct, corresponding to the periplasmic domain of Lep.
v2-75 binds to lipid vesicles and right-side out inner mem-
brane vesicles equally well, suggesting that the catalytic do-
main does not bind to proteinaceous components present in
the inner membrane but directly to the membrane lipids.
The binding to lipids was also demonstrated by the e⁄cient
insertion of v2-75 into monolayers derived from inner mem-
brane lipids. Remarkably, while anionic phospholipids are
often important for the insertion of proteins [26,27], v2-75
displayed best penetration in lipid ¢lms made from the zwit-
terionic lipid phosphatidylethanolamine. Insertion thus does
not seem to depend on electrostatic interactions. The limiting
surface pressure for insertion into PE monolayers was very
close to that of complete extracts of the E. coli inner mem-
brane which contain about 75% PE, suggesting that within the
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Fig. 5. Speci¢c interaction of v2-75 with di¡erent lipid head group
classes. The surface pressure increase which is caused by insertion
of v2-75 into monolayers of DOPE (triangles), DOPC (squares) and
DOPG (circles) as function of the initial surface pressure.
Fig. 4. Interaction of v2-75 and v2-98 with monolayers. A: Inser-
tion pro¢le of v2-75 and v2-98 into monolayers of E. coli inner
membrane lipids which were spread at 22 mN/m initial pressure.
After injection of protein the changes in surface pressure were fol-
lowed. B: Ability of v2-75 and v2-98 to penetrate into monolayers
as function of the initial pressure of the monolayer.
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lipid extract the PE component is responsible for insertion of
v2-75. The preference of the periplasmic domain for binding
to the outer membrane (Fig. 1B) is compatible with a speci¢c
binding to the PE component, since the periplasmic lea£et of
the outer membrane is enriched in PE over the inner mem-
brane [28].
The zwitterionic nature of the PE headgroup is not respon-
sible for the speci¢c interaction with the catalytic domain of
leader peptidase because insertion into monolayers of the
zwitterionic PC is greatly reduced. In recent years it has be-
come increasingly clear that PE has special properties allow-
ing it to mediate membrane insertion and binding of proteins
(for review see [29]). Examples include insertion of the chloro-
plast precursor protein of ferredoxin [21], the precursor of
the E. coli pore protein PhoE [30], SecA [27], and blood co-
agulation factor VIII [31]. Furthermore, PE promotes folding
of a periplasmic loop of newly inserted lactose permease [32],
it regulates the activity of glycerophosphate acyltransferase
[33], it is essential for e⁄cient functioning of preprotein trans-
locase [34], and was recently found in crystals of cytochrome c
oxidase [35].
The hypothesis has been put forward [36] that PE as non-
bilayer lipid with its small headgroup in conjunction with a
strong tendency of this lipid to organize in structures with a
high intrinsic negative surface curvature when constrained
within a bilayer, lowers the lateral pressure in the interface.
This could create insertion sites for proteins or for other am-
phipatic components as the anti-cancer drug doxorubicine
[37]. It is this property that may be responsible for insertion
of the catalytic domain of leader peptidase into the periplas-
mic lea£et of the E. coli inner membrane.
It is not possible to draw ¢rm conclusions about the part of
P2 which is responsible for the interactions with membranes
containing phosphatidylethanolamine. However, considering
the nature and speci¢city of the interaction between the peri-
plasmic domain of Lep and lipids it is most likely that mem-
brane association is caused by interaction of a hydrophobic
segment within the periplasmic domain with the lipids. Dele-
tion of H3 (residues 83^98) which is the most hydrophobic
part within the periplasmic domain indeed diminished both
insertion into the lipid monolayers and association with the
lipid vesicles.
The insertion into the lipid phase as described in this study
has important implications for the mode of action of Lep.
Because of the short hydrophobic core and the cytosolic local-
isation of the N-termini of signal sequences, the catalytic site
of Lep must be very close to the membrane. Insertion of the
periplasmic domain into the lipid phase and the possible in-
volvement of H3, which carries the catalytic serine-90 residue,
implies that the active site of Lep may be at least partially
buried in the membrane.
Interestingly, it has been observed that lengthening the hy-
drophobic core of signal sequences results in reduced process-
ing of preproteins without much e¡ect on translocation [38].
Our data suggest that the signal peptide cleavage site may
have been moved too far out of the membrane to be accessible
to the active site of leader peptidase under these conditions.
Acknowledgements: The authors thank Anja Ridder, Anne van
Raalte, Antoinette Killian and Hans Wienk for helpful discussions.
References
[1] von Heijne, G. (1985) J. Mol. Biol. 184, 99^105.
[2] Date, T. and Wickner, W. (1981) Proc. Natl. Acad. Sci. USA 78,
6106^6110.
[3] von Heijne, G. (1983) Eur. J. Biochem. 133, 17^21.
[4] Fikes, J.D., Barkocy-Gallagher, G.A. and Klapper, D.G. (1990)
J. Biol. Chem. 265, 3417^3423.
[5] Black, M.T. (1993) J. Bacteriol. 175, 4957^4961.
[6] Tschantz, W.R., Sung, M., Delgado, P.V. and Dalbey, R.E.
(1993) J. Biol. Chem. 268, 27349^27354.
[7] Kuhn, A. (1987) Science 238, 1413^1415.
[8] Shaw, A.S., Rottier, P.J. and Rose, J.K. (1988) Proc. Natl. Acad.
Sci. USA 85, 7592^7596.
[9] Kuo, D.W., Chan, H.K., Wilson, C.J., Gri⁄n, P.R., Williams, H.
and Knight, W.B. (1993) Arch. Biochem. Biophys. 303, 274^280.
[10] Tschantz, W.R., Paetzel, M., Cao, G., Suciu, D., Inouye, M. and
Dalbey, R.E. (1995) Biochemistry 34, 3935^3941.
[11] Bligh, E.G. and Dyer, W.J. (1959) Can. J. Biochem. Physiol. 37,
911^917.
[12] Smaal, E.B., Romijn, D., Geurts van Kessel, W.S.M., de Kruij¡,
B. and de Gier, J. (1985) J. Lipid Res. 26, 634^637.
[13] Sasakawa, L. and Yoshikawa, M. (1987) Gene 56, 283^288.
[14] Nilsson, I. and von, H.G. (1991) J. Biol. Chem. 266, 3408^3410.
[15] Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) Molecular
Cloning, Cold Spring Harbor Laboratory, Cold Spring Harbor,
NY.
[16] Kaback, H.R. (1971) Methods Enzymol. 22, 99^120.
[17] de Vrije, T., Tommassen, J. and de Kruij¡, B. (1987) Biochim.
Biophys. Acta 900, 63^72.
[18] Rouser, G., Fleischer, S. and Yamamoto, A. (1970) Lipids 5,
494^496.
[19] Demel, R.A. (1994) Subcell. Biochem. 23, 83^120.
[20] Bilgin, N., Lee, J.I., Zhu, H.Y., Dalbey, R. and von Heijne, G.
(1990) EMBO J. 9, 2717^2722.
[21] van’t Hof, R., van Klompenburg, W., Pilon, M., Kozubek, A., de
Korte Kool, G., Demel, R.A., Weisbeek, P.J. and de Kruij¡, B.
(1993) J. Biol. Chem. 268, 4037^4042.
[22] Demel, R.A., London, Y., Geurts van Kessel, W.S.M., Vossen-
berg, F.G.A. and van Deenen, L.L.M. (1973) Biochim. Biophys.
Acta 311, 507^519.
[23] Demel, R.A., Geurts van Kessel, W.S.M., Zwaal, R.F.A., Roe-
lofsen, B. and van Deenen, L.L.M. (1975) Biochim. Biophys.
Acta 406, 97^107.
[24] Raetz, C.R.H. (1978) Microbiol. Rev. 42, 614^659.
[25] de Kruij¡, B. (1994) FEBS Lett. 346, 78^82.
[26] Batenburg, A.M., Demel, R.A., Verkleij, A.J. and de Kruij¡, B.
(1988) Biochemistry 27, 5678^5685.
[27] Breukink, E., Demel, R.A., de Korte-Kool, G. and de Kruij¡, B.
(1992) Biochemistry 31, 1119^1124.
[28] Lugtenberg, E.J.B. and Peters, R. (1976) Biochim. Biophys. Acta
441, 38^47.
[29] de Kruij¡, B. (1997) Curr. Opin. Chem. Biol 1, 564^569.
[30] van Raalte, A.L.J., Demel, R.A., Verberkmoes, G., Breukink, E.,
Keller, R.C.A. and de Kruij¡, B. (1996) Eur. J. Biochem. 235,
207^214.
[31] Gilbert, G.E. and Arena, A.A. (1995) J. Biol. Chem. 270, 18500^
18505.
[32] Bogdanov, M., Sun, J., Kaback, H.R. and Dowhan, W. (1996)
J. Biol. Chem. 271, 11615^11618.
[33] Snider, M.D. and Kennedy, E.P. (1977) J. Bacteriol. 130, 1072^
1083.
[34] Rietveld, A.G., Koorengevel, M.C. and de Kruij¡, B. (1995)
EMBO J. 14, 5506^5513.
[35] Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yama-
guchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R. and
Yoshikawa, S. (1996) Science 272, 1136^1144.
[36] de Kruij¡, B. (1997) Nature 386, 129^130.
[37] Speelmans, G., Sta¡horst, R.W.H.M. and de Kruij¡, B. (1997)
Biochemistry 36, 8657^8662.
[38] Chou, M.M. and Kendall, D.A. (1990) J. Biol. Chem. 265, 2873^
2880.
FEBS 20496 13-7-98
W. van Klompenburg et al./FEBS Letters 431 (1998) 75^79 79
